Dry Eye Syndrome Market Size, Share, Trends & Forecast

The Dry Eye Syndrome Market was valued at approximately USD 6.80 billion in 2025 and is projected to reach around USD 10.30 billion by 2035, registering a CAGR of approximately 4.25% during 2026–2035. Rising screen exposure, an aging population, increasing diagnosis rates, and advances in prescription therapies and diagnostic technologies are supporting market growth. ๎ˆ

Increasing exposure to digital screens is contributing to greater awareness and diagnosis of dry eye conditions. Extended screen use can reduce blinking and contribute to tear-film instability, creating demand for treatments and diagnostic services.

Prescription therapies represent the largest treatment modality, accounting for approximately 45.3% of the market in 2025. Anti-inflammatory and immunomodulatory treatments are gaining attention as healthcare providers increasingly focus on managing the underlying causes of dry eye rather than providing only temporary symptom relief.

Eye drops remain the dominant dosage form, representing approximately 70.2% of the market in 2025. Their familiarity and ease of administration continue to support widespread use, while preservative-free formulations and alternative delivery methods are creating new opportunities.

Diagnostic testing is also expected to expand, with the segment projected to register a 7.10% CAGR through 2035. Tear osmolarity testing and meibography are becoming increasingly important for identifying disease severity and subtype.

The continued development of prescription therapies, diagnostic devices, preservative-free products, and advanced treatment approaches is expected to support the long-term expansion of the global dry eye treatment ecosystem.

Read More
Lukoon https://lukoon.com